40 likes | 146 Views
Supplementary Figure 1. Venkatachalam et al. 2013. ab. a. ab. abc. c. 24 48 72 96 120. Hours after FB17 treatment. Supplementary Figure 2. Venkatachalam et al. 2013. At1g11610. At3g28360. At1g21240. At3g14460. At3g20190. UBQ1.
E N D
Supplementary Figure 1 Venkatachalam et al. 2013 ab a ab abc c 24 48 72 96 120 Hours after FB17 treatment
Supplementary Figure 2 Venkatachalam et al. 2013 At1g11610 At3g28360 At1g21240 At3g14460 At3g20190 UBQ1 FB17 - + - + - + - + - + - + - + - + - + - + at3g20190 at3g14460 at1g21240 at1g11610 Col-0 Col-0 Col-0 Col-0 Col-0 at3g28360
Supplementary Figure 3 Venkatachalamet al. 2013 Col-0 Col-0 Col-0 Col-0 Col-0 At5g56320 At5g43350 At4g19690 At5g01220 At3g27980 UBQ1 FB17 - + - + - + - + - + - + - + - + - + - + at5g43350 at5g56320 at4g19690 at5g01220 at3g27980
Supplementary Figure 4 Venkatachalam et al. 2013 Col-0 at2g47620 at2g33160 at2g40930 at2g26540 at5g12350 at5g19460 at5g19830 at5g13120 at5g09480